Ohcanbohtosat - Garry Forgeson
- Čájehuvvo 1 - 2 / 2
-
1
ChlVPP combination chemotherapy for Hodgkin's disease: long term results Dahkki Peter Selby, Pushpa Patel, S Milan, M Meldrum, Janine Mansi, Edward Mbidde, M. Brada, Timothy Perren, Garry Forgeson, M. Gore
Almmustuhtton 1990Artigo -
2
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX... Dahkki Niall C. Tebbutt, Kate Wilson, Val Gebski, Michelle M. Cummins, Diana Zannino, Guy A. Van Hazel, Bridget A. Robinson, A. Broad, Vinod Ganju, Stephen P. Ackland, Garry Forgeson, David Cunningham, Mark Saunders, Martin R. Stockler, Yujo Chua, John Zalcberg, R. J. Simes, Timothy Price
Almmustuhtton 2010Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Chemotherapy
Gastroenterology
Internal medicine
Medicine
Surgery
ABVD
Bevacizumab
Biology
Cancer
Capecitabine
Chemotherapy regimen
Chlorambucil
Colorectal cancer
Combination chemotherapy
Confidence interval
Cyclophosphamide
Disease
Hazard ratio
Multivariate analysis
Oncology
Paleontology
Prednisolone
Procarbazine
Progression-free survival
Radiation therapy
Randomized controlled trial
Stage (stratigraphy)
Univariate analysis
Vinblastine
Vincristine